News
Novo Nordisk continues to expand its partnerships with telehealth companies to broaden access to its blockbuster weight loss ...
Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy ...
Novo Nordisk NVO announced that it has ended its collaboration with telehealth provider Hims & Hers Health. In addition, the ...
After ousting CEO, Novo Nordisk reclaims crown as largest European company Last Updated: June 13, 2025 at 7:14 a.m. ET First Published: June 13, 2025 at 4:48 a.m. ET Share ...
[COPENHAGEN] Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP. Shares in the Danish drugmaker climbed as much as 2.3 per cent on Friday ...
Please use one of the following formats to cite this article in your essay, paper or report: APA. Molecular Devices UK Ltd. (2025, June 13). Rapid screening with patient-derived 3D organoids.
LONDON (Reuters) -Drugmaker Novo Nordisk is once again Europe's largest company by market capitalisation, rising above German software firm SAP on Friday. The Danish company reached $367.91 ...
Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. Novo Nordisk's ADR (NVO) (DK:NOVO.B), at ...
Positive news from the laboratory was the wind beneath the wings of Novo Nordisk (NYSE: NVO) stock on Thursday. The Denmark-based pharmaceutical company, famed for its Ozempic and Wegovy drugs ...
In March, Novo Nordisk announced headline results from the REDEFINE 2 phase 3 trial in the global REDEFINE program. REDEFINE 2 is a 68-week efficacy and safety trial investigating once-weekly ...
Activist hedge fund Parvus Asset Management is building a stake in Novo Nordisk, the maker of Ozempic, as the Danish drugmaker searches for a new chief executive amid a sharp decline in its share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results